Shailaja
Shailaja Gummadidala, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20150355836 | TEXT INPUT SYSTEM AND METHOD - The present invention relates to a computer-implemented method for inputting text into an electronic device ( | 12-10-2015 |
Shailaja Jayaramachandran, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20100261902 | Fluoride-Releasing Compositions - Chelating monomers and fluoride-releasing compositions are disclosed that may be incorporated into dental composite restorative materials, dental bonding agents or other dental materials, to produce materials with high fluoride release rates, and high fluoride recharge capability. Such dental restorative materials may help reduce the level of dental caries in patients, particularly the level of caries occurring on the margins of the restorative materials. | 10-14-2010 |
20120264939 | Fluoride-Releasing Compositions - Chelating monomers and fluoride-releasing compositions are disclosed that may be incorporated into dental composite restorative materials, dental bonding agents or other dental materials, to produce materials with high fluoride release rates, and high fluoride recharge capability. Such dental restorative materials may help reduce the level of dental caries in patients, particularly the level of caries occurring on the margins of the restorative materials. | 10-18-2012 |
20140088308 | Fluoride-Releasing Compositions - Chelating monomers and fluoride-releasing compositions are disclosed that may be incorporated into dental composite restorative materials, dental bonding agents or other dental materials, to produce materials with high fluoride release rates, and high fluoride recharge capability. Such dental restorative materials may help reduce the level of dental caries in patients, particularly the level of caries occurring on the margins of the restorative materials. | 03-27-2014 |
Shailaja Kamila, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150142942 | NETWORK STORAGE MANAGEMENT AT SCALE USING SERVICE LEVEL OBJECTIVES - Technology is disclosed for managing network storage services by service level objectives (SLOs). The method receives multiple service level capability (SLC) templates; creates at least one storage service level (SSL) instance using at least one of the SLC templates; provisions a storage object located in a network storage infrastructure based on the SSL instance; and services storage requests using the storage object. | 05-21-2015 |
Shailaja Kamila, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20100106933 | METHOD AND SYSTEM FOR MANAGING STORAGE CAPACITY IN A STORAGE NETWORK - A system for managing configuration of a storage network having multiple storage resources is disclosed. The system uses a storage management policy to set parameters for detecting storage resource problems in the storage network. The system monitors the storage resources in the storage network based on the storage management policy. Based on the monitoring, the system detects limited storage resource conditions, and identifies one or more potential solutions to the condition. After identifying potential solutions, the system simulates effects on the storage resources of implementing individual solutions. Based on the simulations, the system then implements one or more selected solutions. These solutions may be selected automatically or by a user. | 04-29-2010 |
Shailaja Kashibhatla, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120058112 | ANTIBODIES - The combination of an IGF-1R antagonist such as a humanized antibody and an anti-proliferative drug is described. In a preferred embodiment, the present invention describes the combination of an IGF-1R antibody and an anti-proliferative drug belonging to the EGFR-inhibitor class, which is preferably erlotinib. The combination according to the present invention is useful for the treatment of tumours, including IGF-1R and/or EGFR mediated or dependent tumours. | 03-08-2012 |
Shailaja Padamata, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20100261908 | PROCESSES FOR THE PREPARATION OF PRASUGREL , AND ITS SALTS AND POLYMORPHS - Processes for the preparation of prasugrel and its pharmaceutically acceptable salts thereof. Also disclosed are polymorphic forms of prasugrel hydrochloride and processes for their preparation. | 10-14-2010 |
20100274017 | PROCESSES FOR THE PREPARATION OF SITAGLIPTIN AND PHARMACEUTICLLY ACCEPTABLE SALTS THEREOF - There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical compositions comprising the same. | 10-28-2010 |
20130035486 | PROCESSES FOR THE PREPARATION OF SITAGLIPTIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical composition comprising the same. | 02-07-2013 |
20140128607 | PROCESSES FOR THE PREPARATION OF SITAGLIPTIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical compositions comprising the same. | 05-08-2014 |
Shailaja Somaraju, Catonsville, MD US
Patent application number | Description | Published |
---|---|---|
20120308617 | PHOSPHOLIPID-BASED INHALATION SYSTEM - The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly preferred embodiment of the invention describes the use of two steps for delivery of a medication. In a first step, an aerosolized therapeutic composition or medication is administered into a patient's respiratory tract, wherein the patient may be any animal or human subject. Following the first step, an aerosolized surfactant is administered into the patient's respiratory tract that facilitates delivery of the aerosolized medication of the first step to the medication's pulmonary target. Another embodiment of the present invention contemplates an apparatus for the delivery of an aerosolized surfactant used that facilitates delivery of previously inhaled aerosolized medication. | 12-06-2012 |
Shailaja Srinagesh, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20150141624 | Anti-CD70 Antibody Drug Conjugates - This invention relates to anti-CD70 antibodies and antibody drug conjugates comprising at least one non-naturally-encoded amino acid. Disclosed herein are αCD70 antibodies with one or more non-naturally encoded amino acids and further disclosed are antibody drug conjugates wherein the αCD70 antibodies of the invention are conjugated to one or more toxins. Further disclosed are methods for using such non-natural amino acid antibody drug conjugates, including therapeutic, diagnostic, and other biotechnology uses. | 05-21-2015 |
20150152187 | Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand Polypeptides - This invention relates to anti-prostate-specific membrane antigen antibodies (αPSMA) and αPSMA antibody—nuclear receptor ligand (NRL) conjugates comprising at least one non-naturally-encoded amino acid. | 06-04-2015 |